Goldmann Perimetry for Pituitary Macroadenoma Assessment
Goldmann perimetry is the visual field test beginning with "G" that is preferred for assessing pituitary macroadenomas. 1
Why Goldmann Perimetry is Preferred
Goldmann perimetry is explicitly recommended as the preferred method for visual field testing in patients with pituitary macroadenoma. 1 This kinetic perimetry technique allows comprehensive mapping of the entire visual field and is particularly effective at detecting the characteristic bitemporal hemianopsia caused by optic chiasm compression. 1
Alternative Testing Options
- Automated static perimetry (such as Humphrey visual field testing) serves as an acceptable alternative when Goldmann perimetry is unavailable. 1
- Automated perimetry reliably detects subtle bitemporal field defects, occasional homonymous defects, and arcuate defects characteristic of optic nerve pathology that patients may not subjectively notice. 1
Complete Visual Assessment Protocol
Beyond visual field testing, comprehensive ophthalmologic evaluation must include:
- Visual acuity measurement using age-appropriate logarithm of the minimum angle of resolution (logMAR) charts to provide quantitative baseline data. 2, 1
- Fundoscopy to evaluate optic disc appearance and optic nerve integrity, which provides prognostic information on visual recovery potential. 1
- Baseline optical coherence tomography (OCT) in patients with potentially severe acuity or field deficits, as retinal nerve fiber layer (RNFL) thickness serves as a surrogate marker for visual field loss. 1
Timing Considerations
- Pre-treatment assessment is mandatory for all patients with suspected or confirmed pituitary macroadenoma to identify asymptomatic visual deficits and establish baseline for comparison. 1
- Post-treatment follow-up should occur within 3 months of first-line therapy, as further recovery of visual field deficits is unlikely after the first postoperative month. 2, 1
Clinical Pitfalls
Visual field defects can occur even without suprasellar extension on imaging, while some patients with suprasellar masses elevating the chiasm may paradoxically have normal visual fields. 3 Therefore, never rely on imaging alone to predict visual involvement—always perform formal visual field testing regardless of tumor appearance on MRI. 3